Anthropic plans Nasdaq listing with revenue above $16 bn

Anthropic filed an S-1 prospectus on Oct. 26 for a Nasdaq IPO under ANT, disclosing revenue of more than $16 billion through the first half of 2026.

The filing puts Anthropic’s rapid growth and still-negative earnings before public investors. The Claude maker reported an $80.7 million net loss in the first half, compared with $13 billion a year earlier, while leaving the offer size and valuation blank.

An S-1 is the U.S. registration statement companies file before selling shares to the public. Anthropic’s document gives investors their first formal view of how the company describes its business, financial profile and risks.

Anthropic said enterprise demand has expanded sharply. More than 11,900 customers spent at least $100,000 over the past 12 months; more than 1,900 spent at least $1 million; and about 250 spent $10 million or more.

“The advent of machine intelligence is one of the seminal moments in human history,” Anthropic wrote in the filing. “We encourage you, as a prospective owner of our stock, not to think of your purchase in purely transactional terms.”

The prospectus does not say how much Anthropic wants to raise or what valuation it will seek. The New York Times reported in August that the company was looking to raise more than $100 billion at a valuation of around $2 trillion, while The Wall Street Journal reported the IPO could come later in November.

The filing also gives a broad account of the hazards attached to Anthropic’s business. The company said investment in its stock carries “a high degree of risk,” citing access to computing capacity, pressure from competing AI developers and the possibility that advanced systems could “pose catastrophic or existential risks to humanity.”

Anthropic said in the filing that advanced AI could be misused for cyberattacks, biological-weapons development or state surveillance. It also cited the possibility that the company could lose control of models it builds, and pointed to the Trump Administration’s decision to designate Anthropic as a supply-chain risk.

The government issue could affect sales, according to the filing. “While we continue to work with government agencies, we cannot be certain that the resolution of these lawsuits will not adversely affect our ability to sell to government agencies and other customers that sell products and services to the U.S. government, and in turn adversely affect our business, financial condition, and results of operations,” Anthropic wrote.

Anthropic’s planned listing comes as rival OpenAI has stepped back from a near-term IPO. OpenAI, which WIRED reported filed confidentially for an IPO during the summer, said in September it no longer intended to go public this year, citing concerns about AI risks.

Anthropic was founded in 2021 by seven former OpenAI employees and has marketed itself as focused on AI safety. The filing says the company aims to build advanced models that can accelerate scientific discovery, help cure disease and support economic growth.

“To build AI is to harness cognition itself, and anything so powerful can be used for ill as well as good,” the company wrote. Anthropic did not immediately respond to WIRED’s request for comment.

Source: S-1 prospectus and WIRED report, Oct. 26, 2026